Letters Prostate cancer screening What is mortality denominator? BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3702 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3702 Article Related content Metrics Responses Peer review Related articles Research Randomised prostate cancer screening trial: 20 year follow-up Published: 31 March 2011; BMJ 342 doi:10.1136/bmj.d1539 Letter Authors’ reply Published: 14 June 2011; BMJ 342 doi:10.1136/bmj.d3710 See more Breast cancer: Inaction on inequalities has led to unequal progress, say experts BMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854 Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchers BMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818 NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Teledentistry may help in detecting oral cancers in current GP and dentist shortages BMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512 UK’s progress on cancer survival has slowed in past decade, figures show BMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290 Cited by... Authors' replyFulltext PDF
